Partners Group Acquires Majority Stake in FairJourney Biologics from GHO Capital
July 1, 2024
Partners Group has acquired a majority stake in FairJourney Biologics from GHO Capital; GHO will reinvest as a minority investor and founder António Parada remains invested. The transaction will further capitalise FairJourney to expand its antibody discovery and development capabilities, scientific leadership and global footprint.
- Buyers
- Partners Group
- Targets
- FairJourney Biologics
- Sellers
- GHO Capital Partners LLP
- Industry
- Biotechnology
- Location
- Porto, Portugal
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.